TRANSDERMAL PREPARATION OF THE PROLONGED EFFECT SHOWING ANTIOSTEOPOROTIC ACTIVITY

摘要

FIELD: medicine, pharmacy. SUBSTANCE: preparation has estrogen as an active component an at least one carrier or additional substance. The indicated components and their amounts are taken to provide continuous estrogen releasing for at least 24 h. Preparation has estriol at effective amount as an estrogen. Proposed preparation ensures to control climacteric osteoporosis without arising the enhanced risk of cancer falling ill, in part, breast cancer. EFFECT: enhanced effectiveness of preparation proposed. 7 cl, 4 tbln